Laser Vision Correction Market , by Procedure (LASIK (Laser Assisted In-Situ Keratomileusis), PRK (Photo Refractive Keratectomy), SMILE (Small Incision Lenticule Extraction) and Others), by Type (Excimer Laser and Femtosecond Laser), By Therapeutic Application (Myopia, Hyperopia, Presbyopia, Astigmatism, Cataract, and Others), by End User (Hospitals, Specialty Clinics, and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) -

Published In : Jul 2023

Code : CMI3996

Pages :198

Formats :

Excel and PDF

Industry : Medical Devices

Market News

Global Laser Vision Correction Market: Key Developments

In March 2022, SMS Healthcare (a part of the SMS Holdings family of companies), acquired LASERSIGHT Australia, an eye care provider.

In December 2022, Vision Innovation Partners, a U.S.-based eye care platform with over 70 locations, announced that it partnered with Chosen Laser Eye Center, a company specialized in providing personalized and individualized vision care, to strengthen its network of differentiated ophthalmology practices.

In January 2022, EuroEyes UK (a subsidiary of EuroEyes), a global vision correction service provider, acquired London Vision Clinic, a laser eye surgery clinic based in the U.K., to expand its products and service offerings.

On January 12, 2023, Sunvera Group, a company providing support services to ophthalmology practices, formed a new partnership with Zimm Cataract & Laser Center, a provider of a collection of services such as cataract surgery, LASIK vision correction, and comprehensive eye care and its affiliate, Premier Surgical Center, an ophthalmic-focused ambulatory surgery center, to establish Sunvera Group’s presence in the Pennsylvania, U.S. market and extend its network ophthalmology practices and surgery centers.

Global Laser Vision Correction Market: Key Trends

In May 2022, London Vision Clinic (a subsidiary of EuroEyes UK ), a clinic that offers laser eye surgery treatments, announced the development of a new flap-less ReLEx SMILE procedure which is a minimally-invasive laser eye surgery technique. SMILE does not require the removal of epithelium from the cornea. Instead, surgeons are able to access and draw out tissue from the corneal bed through a tiny keyhole, created using a precise laser.

The growing incidences of approvals from regulatory bodies of respective countries regarding laser vision correction are a major factor leading to the high demand for laser vision correction devices. For instance, in June 2022, LENSAR, Inc., a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, announced that the U.S. Food and Drug Administration (FDA) gave clearance for its next-generation ALLY Adaptive Cataract Treatment System. ALLY enables cataract surgeons to complete the femtosecond-laser-assisted cataract surgery procedure in a single, sterile environment.